In the USA, COVID-19 vaccines became available in mid-December, 2020, with adults aged 65 years and older among the first groups prioritised for vaccination. We estimated the national-level impact of the initial phases of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older.

Matéria original

Anterior

Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids

Próxima

Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments